bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.540
-0.460 (-11.50%)
At close: Mar 30, 2026, 4:00 PM EDT
3.500
-0.040 (-1.13%)
Pre-market: Mar 31, 2026, 8:26 AM EDT

bioAffinity Technologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.451.112.8211.411.36
Cash & Short-Term Investments
6.451.112.8211.411.36
Cash Growth
483.54%-60.83%-75.28%738.85%1537.19%
Accounts Receivable
0.541.140.810.010
Inventory
0.050.030.020.01-
Other Current Assets
0.520.420.320.530.08
Total Current Assets
7.572.73.9711.961.44
Net Property, Plant & Equipment
1.261.621.990.210
Other Intangible Assets
0.720.780.83--
Goodwill
1.41.41.4--
Other Long-Term Assets
0.010.020.020.010.01
Total Assets
10.966.518.2212.181.45
Accounts Payable
0.760.990.60.350.23
Accrued Expenses
1.721.41.150.541.6
Short-Term Debt
---0.2511.15
Current Portion of Long-Term Debt
0.110.17--0.05
Current Portion of Leases
0.280.520.46--
Unearned Revenue
0.040.020.03--
Total Current Liabilities
2.913.12.251.1413.04
Long-Term Debt
0.040.02--0.16
Long-Term Leases
0.740.791.12--
Total Long-Term Liabilities
0.780.811.12-0.16
Total Liabilities
3.683.913.371.1413.2
Preferred Stock
0----
Common Stock
0.0300.070.060.02
Additional Paid-in Capital
75.856.2449.3947.6512.7
Retained Earnings
-68.55-53.64-44.6-36.67-28.51
Total Common Shareholders' Equity
7.282.64.8611.04-15.79
Minority Interest
----4.04
Shareholders' Equity
7.282.64.8611.04-11.75
Total Liabilities & Equity
10.966.518.2212.181.45
Total Debt
1.161.51.580.2511.36
Net Cash (Debt)
5.29-0.41.2411.16-10
Net Cash Growth
---88.87%--
Net Cash Per Share
3.07-0.984.2674.43-
Book Value
7.282.64.8611.04-15.79
Book Value Per Share
4.236.4416.6573.64-
Tangible Book Value
5.160.422.6211.04-15.79
Tangible Book Value Per Share
3.001.058.9873.64-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q